Aurobindo Pharma’s Rivaroxaban Tablets get U.S FDA nod

The approved product is bioequivalent and therapeutically equivalent to the reference listed drug Xarelto 2.5 mg of Janssen Pharmaceuticals Inc

from Industry News, Company News, Manufacturing News, Service Sector | The Hindu https://ift.tt/FD6eyk9

Comments

Popular posts from this blog

Continuous Glucose Monitoring (CGM) Market in the US, 2025